Omid R Faridani

Title: Omid R Faridani: Innovator in Small-RNA Transcriptome Sequencing

Introduction

Omid R Faridani is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of molecular biology, particularly in the area of small-RNA transcriptome sequencing. With a total of 2 patents, his work has the potential to advance our understanding of cellular processes and disease mechanisms.

Latest Patents

Faridani's latest patents include innovative methods for small-RNA transcriptome sequencing and applications thereof. These methods and kits enable the sequencing and quantification of small RNA molecules from minimal starting materials, including single cells. The invention is applicable in various areas, such as preparing small RNA libraries, synthesizing cDNA from small RNAs, characterizing small RNAs from different cell types, studying cellular heterogeneity in pathological conditions, and diagnosing diseases.

Another notable patent involves methods and compositions for cDNA synthesis and single-cell transcriptome profiling using a template switching reaction. This application discloses improved techniques for cDNA synthesis that enhance reverse transcription, template switching, and preamplification. These advancements lead to increased yield and average length of cDNA libraries generated from individual cells. The new methods incorporate the use of locked nucleic acids and optimized conditions, resulting in full-length coverage, improved sensitivity, and accuracy in single-cell transcriptome analyses.

Career Highlights

Omid R Faridani is associated with the Ludwig Institute for Cancer Research Limited, where he continues to push the boundaries of research in cancer biology. His work is instrumental in developing techniques that can be utilized in both research and clinical settings.

Collaborations

Faridani has collaborated with notable researchers in his field, including Rickard Sandberg and Simone Picelli. These collaborations have further enriched his research and contributed to the advancement of innovative methodologies in transcriptome analysis.

Conclusion

Omid R Faridani's contributions to small-RNA transcriptome sequencing represent a significant advancement in molecular biology. His patents and ongoing research have the potential to impact various fields, including cancer research and diagnostics.